← Evidence map

TrialCancer immunology, immunotherapy : CII2012

Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.

Mark R Albertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

51 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22678096